Lv748
3308 积分 2024-09-08 加入
BUB1 regulates non-homologous end joining pathway to mediate radioresistance in triple-negative breast cancer
9天前
已完结
Olaparib combined with CDK12-IN-3 to promote genomic instability and cell death in ovarian cancer
19天前
已完结
Targeting the SPC25/RIOK1/MYH9 Axis to Overcome Tumor Stemness and Platinum Resistance in Epithelial Ovarian Cancer
26天前
已完结
Targeting GPX4-mediated ferroptosis protection sensitizes BRCA1-deficient cancer cells to PARP inhibitors
1个月前
已完结
PARP Inhibitors plus Anlotinib as Bridging Therapy for Armored CAR-T Cells in Ovarian Cancer Enhances Infiltration and Antitumor Efficacy
1个月前
已完结
AI-powered dynamic scattering liquid crystal biosensor for label-free detection of ovarian cancer biomarker CA125
1个月前
已关闭
Codon specific readthrough as a mechanism of BRCA2 restoration in acquired PARP inhibitor and chemotherapy resistance
1个月前
已完结
Ovarian Cancer
2个月前
已完结
皖公网安备34019202002308
